UAE

Life and Living

World

Opinion

Business

Sports

Entertainment

Dubai World Cup

lifestyle

Travel

Reviews

Brands

Supplements

KT Events

KT APPDOWNLOAD

Trump upbeat on three coronavirus vaccine candidates

Top Stories

Embracing the bright side: A guide on how to cultivate optimism

The power of solitude: Why you should go on a solo trip

How to get your kids to read: Essential tips for parents
Trump, optimism, coronavirus, Covid-19, vaccine, United States
U.S. President Donald Trump swings a wooden baseball bat as he attends a "Spirit of America Showcase" event in the Cross Hall of the White House in Washington, U.S., July 2, 2020.

Washington, United States - US health expert insists a safe and effective vaccine for Covid-19 will be available by year-end to meet a target of making 300 million doses by early 2021.

By Reuters

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Published: Thu 2 Jul 2020, 10:55 PM

Last updated: Fri 3 Jul 2020, 1:09 AM

U.S. President Donald Trump on Thursday voiced optimism the United States would soon come up with a vaccine for the novel coronavirus, saying three vaccine candidates were looking especially good.
"Three are really, really looking good," Trump said at an event at the White House, without providing details. "We think we're going to have it soon."
U.S. National Institutes of Health Director Dr. Francis Collins said earlier on Thursday that he was optimistic the Trump administration's vaccine-acceleration programme "Operation Warp Speed" will generate a safe and effective vaccine for Covid-19 by year-end and can meet a target of making 300 million doses by early 2021.
Speaking at a U.S. Senate hearing, Collins said the United States aimed to have the ability to conduct a million rapid, on-site Covid-19 tests per day some time around September to enable the reopening of schools and resumption of sports events.
"That's really a stretch goal, but it's the right goal for the American people," he said.
Dr. Gary Disbrow, acting director of the Biomedical Advanced Research and Development Authority (BARDA), said that the U.S. government was trying to negotiate the lowest possible price for a vaccine. Still, he said that the country would likely have to pay more for any vaccine not developed with government funding.
BARDA has provided funds for three vaccine candidates being developed under Operation Warp Speed by Moderna Inc, Johnson & Johnson and AstraZeneca Plc.
The U.S. Department of Health and Human Services said last month that the administration aimed to narrow its financial support to about seven experimental coronavirus vaccines from the previous 14.
The number of U.S. Covid-19 infections has surged over the past week, with daily figures setting new records several times fuelled by outbreaks in Texas, California, Florida and Arizona.


More news from